Targeting the LPA1 signaling pathway for fibrosis therapy: a patent review (2010-present)
{{output}}
Introduction: Fibrosis is a disease that damages organs and even causes death. Because of the complicated pathogenesis, the development of drugs for fibrosis is challenging. In the lysophosphatidic acid receptor type 1 (LPA1) sig... ...
